BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12244619)

  • 1. Protective efficacy and antibody follow-up of hepatitis B vaccine within the South African expanded programme on immunisation.
    Mphahlele MJ; Tshatsinde EA; Burnett RJ; Aspinall S
    S Afr Med J; 2002 Aug; 92(8):612-3. PubMed ID: 12244619
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunogenicity of a low-cost hepatitis B vaccine in the South African Expanded Programme on Immunisation.
    Aspinall S; Kocks DJ
    S Afr Med J; 1998 Jan; 88(1):36-9. PubMed ID: 9539933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the best hepatitis B vaccination strategy for South Africa?
    Karim SS
    S Afr Med J; 1998 Jun; 88(6):693-4. PubMed ID: 9687844
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunogenicity of hepatitis B vaccine incorporated into the expanded program of immunization schedule.
    Gomber S; Sharma R; Ramachandran VG; Talwar V; Singh B
    Indian Pediatr; 2000 Apr; 37(4):411-3. PubMed ID: 10781235
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunogenicity and safety of yeast-derived recombinant hepatitis B vaccine (Heberbiovac HB) in South African children.
    Mphahlele MJ; Burnett RJ; Kyaw T; Schoeman HS; Aspinall S
    S Afr Med J; 2004 Apr; 94(4):280-1. PubMed ID: 15150941
    [No Abstract]   [Full Text] [Related]  

  • 6. An update after 16 years of hepatitis B vaccination in South Africa.
    Burnett RJ; Kramvis A; Dochez C; Meheus A
    Vaccine; 2012 Sep; 30 Suppl 3():C45-51. PubMed ID: 22939021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of a low dose of indigenously developed recombinant hepatitis-B vaccine in neonates and infants.
    Rao MN; Joshi N; Habibullah CM
    Indian Pediatr; 1999 Jun; 36(6):581-3. PubMed ID: 10736587
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis B vaccine in the expanded programme of immunisation: The Gambian experience. The Gambia Hepatitis Study Group.
    Lancet; 1989 May; 1(8646):1057-9. PubMed ID: 2566008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.
    Van Damme P; Van Herck K
    Expert Rev Vaccines; 2004 Jun; 3(3):249-67. PubMed ID: 15176942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001.
    Van Damme P; Vorsters A
    J Med Virol; 2002 Jul; 67(3):433-9. PubMed ID: 12116040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical efficacy and immunologic responses of hepatitis B vaccination in very-low-birth-weight infants.
    Yang YJ; Lin CH; Tai YT; Huang SC; Lin YJ
    Pediatr Infect Dis J; 2008 Aug; 27(8):768. PubMed ID: 18574432
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hepatitis B immunization for newborn infants of hepatitis B surface antigen-positive mothers].
    Cowan SA; Qureshi KM
    Ugeskr Laeger; 2007 Oct; 169(41):3471-4. PubMed ID: 17967274
    [No Abstract]   [Full Text] [Related]  

  • 13. [Basic immunization hexvalent vaccine. Are there differences between vaccines?].
    MMW Fortschr Med; 2003 May; 145(19):54. PubMed ID: 12813984
    [No Abstract]   [Full Text] [Related]  

  • 14. [Increased risk of hepatitis B due to incomplete or untimely immunisation in one-quarter of infants of hepatitis-B-virus carriers].
    van der Ploeg CP; Kateman H; Vermeer-de Bondt PE; Verkerk PH
    Ned Tijdschr Geneeskd; 2004 Sep; 148(37):1820-4. PubMed ID: 15495511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the quebec school-based hepatitis B immunization program and potential benefit of the addition of an infant immunization program.
    Gîlca V; Duval B; Boulianne N; Dion R; De Serres G
    Pediatr Infect Dis J; 2006 Apr; 25(4):372-4. PubMed ID: 16567995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination.
    Williams IT; Goldstein ST; Tufa J; Tauillii S; Margolis HS; Mahoney FJ
    Pediatr Infect Dis J; 2003 Feb; 22(2):157-63. PubMed ID: 12586980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B vaccine.
    John TJ
    Indian Pediatr; 1995 Jun; 32(6):715-8. PubMed ID: 8613350
    [No Abstract]   [Full Text] [Related]  

  • 18. Duration of protection after infant hepatitis B vaccination series.
    Middleman AB; Baker CJ; Kozinetz CA; Kamili S; Nguyen C; Hu DJ; Spradling PR
    Pediatrics; 2014 Jun; 133(6):e1500-7. PubMed ID: 24843060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of early hepatitis B immunization programs for newborns and infants.
    Van Herck K; Van Damme P
    Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of hepatitis B vaccination into national immunisation programmes. Alternative strategies must be considered before universal vaccination is adopted.
    Dunn J; Shukla R; Neal K
    BMJ; 1997 Jul; 315(7100):121-2. PubMed ID: 9240065
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.